Events screen · refreshed after the Nov 12, 2026 close
Most negative news tone: Healthcare
Stocks with the most unfavourable news coverage over the past week. Share of articles in the last seven days rated negative for that company by the news provider's model.
| # | Company | Price | Today | Articles 7d | Negative | Positive |
|---|---|---|---|---|---|---|
| 1 | ARDXArdelyxHealthcare | $3.12 | −0.32% | 6 | 6 | 0 |
| 2 | DERMJourney MedicalHealthcare | $4.39 | −1.13% | 4 | 4 | 0 |
| 3 | KLCKinderCare Learning CompaniesHealthcare | $2.11 | −1.40% | 3 | 3 | 0 |
| 4 | ENSGThe Ensign GroupHealthcare | $186.55 | +0.19% | 11 | 9 | 2 |
| 5 | MDGLMadrigal PharmaceuticalsHealthcare | $425.21 | −1.81% | 4 | 3 | 1 |
| 6 | SEPNSepternaHealthcare | $41.86 | −13.80% | 3 | 2 | 0 |
| 7 | HROWHarrowHealthcare | $28.30 | −3.64% | 3 | 2 | 0 |
| 8 | CRMDCorMedixHealthcare | $4.84 | −8.68% | 3 | 2 | 0 |
| 9 | COOThe Cooper CompaniesHealthcare | $62.19 | −1.18% | 3 | 2 | 0 |
| 10 | HIMSHims & Hers HealthHealthcare | $19.73 | −5.19% | 7 | 4 | 1 |
| 11 | NTRANateraHealthcare | $322.94 | +0.98% | 4 | 2 | 1 |
| 12 | TLRYTilray BrandsHealthcare | $2.49 | −4.60% | 5 | 2 | 1 |
| 13 | PTHSPelthos TherapeuticsHealthcare | $8.03 | −14.48% | 3 | 1 | 1 |
| 14 | SMTISanara MedTechHealthcare | $32.54 | +2.94% | 3 | 1 | 0 |
| 15 | LQDALiquidiaHealthcare | $58.12 | +5.27% | 4 | 1 | 2 |
| 16 | IBRXImmunityBioHealthcare | $6.07 | −9.00% | 4 | 1 | 2 |
| 17 | BSXBoston ScientificHealthcare | $44.20 | −2.06% | 4 | 1 | 2 |
| 18 | BMYBristol-Myers SquibbHealthcare | $62.32 | −0.94% | 6 | 1 | 2 |
| 19 | GMEDGLOBUS MEDICALHealthcare | $72.30 | −4.10% | 6 | 1 | 5 |
| 20 | ABTAbbott LaboratoriesHealthcare | $107.25 | −1.87% | 7 | 1 | 5 |
| 21 | JNJJohnson & JohnsonHealthcare | $283.52 | +1.11% | 27 | 2 | 14 |
| 22 | MRNAModernaHealthcare | $231.35 | −6.97% | 15 | 1 | 8 |
| 23 | MRKMerck & Co.Healthcare | $146.95 | −0.16% | 20 | 1 | 9 |
| 24 | LLYEli Lilly &Healthcare | $1,427.28 | −0.70% | 34 | 0 | 23 |
| 25 | PFEPfizerHealthcare | $28.83 | −2.11% | 21 | 0 | 10 |
| 26 | ISRGIntuitive SurgicalHealthcare | $439.89 | −2.14% | 20 | 0 | 16 |
| 27 | ABBVABBVIEHealthcare | $294.45 | −0.18% | 15 | 0 | 9 |
| 28 | MDTMedtronicHealthcare | $100.99 | −0.61% | 12 | 0 | 3 |
| 29 | GKOSGlaukosHealthcare | $246.03 | −0.46% | 11 | 0 | 10 |
| 30 | GILDGilead SciencesHealthcare | $167.95 | −1.05% | 11 | 0 | 7 |
| 31 | WSTWest Pharmaceutical ServicesHealthcare | $411.30 | −0.38% | 10 | 0 | 9 |
| 32 | AMRXAmneal PharmaceuticalsHealthcare | $21.70 | −0.05% | 9 | 0 | 7 |
| 33 | KLACKLAHealthcare | $157.30 | −2.30% | 8 | 0 | 3 |
| 34 | HALOHalozyme TherapeuticsHealthcare | $100.67 | −0.99% | 7 | 0 | 6 |
| 35 | NBIXNeurocrine BiosciencesHealthcare | $169.40 | −2.87% | 6 | 0 | 6 |
| 36 | TGTXTG TherapeuticsHealthcare | $64.56 | −1.82% | 6 | 0 | 6 |
| 37 | RVMDWRevolution Medicines, Inc. WarrantHealthcare | $8.15 | −5.78% | 6 | 0 | 5 |
| 38 | AMGNAmgenHealthcare | $467.06 | −0.22% | 6 | 0 | 2 |
| 39 | RVMDRevolution MedicinesHealthcare | $176.35 | −2.41% | 6 | 0 | 5 |
| 40 | VKTXViking TherapeuticsHealthcare | $27.58 | −3.02% | 5 | 0 | 2 |
| 41 | REGNRegeneron PharmaceuticalsHealthcare | $951.19 | −0.86% | 5 | 0 | 4 |
| 42 | MMSIMerit Medical SystemsHealthcare | $86.69 | −1.57% | 5 | 0 | 4 |
| 43 | ZTSZOETISHealthcare | $82.96 | +0.47% | 5 | 0 | 3 |
| 44 | COLLCollegium PharmaceuticalHealthcare | $24.95 | +0.56% | 5 | 0 | 2 |
| 45 | GEHCGE HealthCare TechnologiesHealthcare | $81.84 | −0.92% | 5 | 0 | 5 |
| 46 | VRTXVertex PharmaceuticalsHealthcare | $542.62 | −0.81% | 5 | 0 | 3 |
| 47 | BTSGBrightSpring Health ServicesHealthcare | $71.45 | −1.61% | 4 | 0 | 4 |
| 48 | TECHBio-TechneHealthcare | $72.84 | +0.05% | 4 | 0 | 3 |
| 49 | BTSGUBrightSpring Health Services, Inc. Tangible Equity UnitHealthcare | $236.03 | −1.38% | 4 | 0 | 4 |
| 50 | TEVATeva Pharmaceutical Industries LimitedHealthcare | $43.65 | +0.95% | 4 | 0 | 2 |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Related screens
Informational screen, not a recommendation.